Skip to main content
International Flavors & Fragrances Inc. (IFF)
NYSE: IFF · Real-Time Price · USD
80.38
-2.27 (-2.75%)
Nov 12, 2026, 4:00 PM EST - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Taste Revenue
2.64B2.48B2.43B
Health & Biosciences Revenue
2.33B2.28B2.20B
Scent Revenue
2.62B2.48B2.44B
Food Ingredients Revenue
-3.28B3.37B
Pharma Solutions Revenue
-369.00M1.05B
Revenue (Other)
1.64B--
Revenue (Total)
9.23B10.89B11.48B

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Taste Adjusted Operating EBITDA
498.00M478.00M460.00M
Health & Biosciences Adjusted Operating EBITDA
581.00M594.00M577.00M
Scent Adjusted Operating EBITDA
520.00M515.00M545.00M
Food Ingredients Adjusted Operating EBITDA
-423.00M408.00M
Pharma Solutions Adjusted Operating EBITDA
-76.00M215.00M
Operating Income (Total)
688.00M-382.00M766.00M

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Nourish Capital Expenditures
322.00M235.00M
Health & Biosciences Capital Expenditures
145.00M73.00M
Scent Capital Expenditures
89.00M70.00M
Pharma Solutions Capital Expenditures
38.00M85.00M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Taste - Comparable Currency Neutral Sales Growth
4.00%-
Food Ingredients - Comparable Currency Neutral Sales Growth
-3.00%-
Health & Biosciences - Comparable Currency Neutral Sales Growth
3.00%8.00%
Scent - Comparable Currency Neutral Sales Growth
3.00%12.00%
Pharma Solutions - Comparable Currency Neutral Sales Growth
12.00%2.00%
Consolidated Comparable Currency Neutral Sales Growth
2.00%6.00%